Thursday, November 20, 2008 7:33:48 PM
Tiger, you've been right, why run away from that. I respect your posts, it took me a while to understand where you were headed.
Personally speaking, and I've been saying this for a while, revenues will be our first step. We've been shipping for Quest, the volume I don't know. These revenues should show up in the 3rd quarter. We only have another month to go, but we should see improvement.
Some investors want to pre-buy revenue growth. They see that Quest and ABC are buying, Advinus looks to be very promising, and expect MAYO to step up soon.
Some wild cards still remain, the rumor has always been, 5 promising contracts in the works. Obviously QUEST and MAYO look to be 1 & 2. TATA could be 3, So that leaves us 2 possible leaders in the CRO field still left. As I mentioned earlier, I'm keeping my eyes on Quintiles ,Covance and Lab Corp. If we could add just one of these to the roster, will move up to first class. Will we become a major player in cold chain transportation.
Our financials or any forecast from Mr. Berry looking forward, are key for us, more important than market stabilization. It would certainly help if we could have a healthy market, but not necessary for what we need.
GLTA
RMS
Personally speaking, and I've been saying this for a while, revenues will be our first step. We've been shipping for Quest, the volume I don't know. These revenues should show up in the 3rd quarter. We only have another month to go, but we should see improvement.
Some investors want to pre-buy revenue growth. They see that Quest and ABC are buying, Advinus looks to be very promising, and expect MAYO to step up soon.
Some wild cards still remain, the rumor has always been, 5 promising contracts in the works. Obviously QUEST and MAYO look to be 1 & 2. TATA could be 3, So that leaves us 2 possible leaders in the CRO field still left. As I mentioned earlier, I'm keeping my eyes on Quintiles ,Covance and Lab Corp. If we could add just one of these to the roster, will move up to first class. Will we become a major player in cold chain transportation.
Our financials or any forecast from Mr. Berry looking forward, are key for us, more important than market stabilization. It would certainly help if we could have a healthy market, but not necessary for what we need.
GLTA
RMS
Recent CYRX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/05/2026 06:36:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/04/2026 08:30:40 PM
- Cryoport Reports First Quarter 2026 Financial Results • PR Newswire (US) • 05/04/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/24/2026 12:00:17 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/22/2026 08:32:31 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/22/2026 08:31:32 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/22/2026 08:30:45 PM
- Cryoport to Report First Quarter 2026 Financial Results on May 4, 2026 • PR Newswire (US) • 04/20/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 10:32:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 12:01:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 12:00:50 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 12:00:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:01:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:00:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:00:11 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/12/2026 08:17:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 10:10:46 PM
- Cryoport Reports Fourth Quarter and Full-Year 2025 Financial Results • PR Newswire (US) • 03/03/2026 09:05:00 PM
- Cryoport to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026 • PR Newswire (US) • 02/17/2026 01:00:00 PM
- Cryoport's MVE Biological Solutions Introduces New Fusion® 800 Series • PR Newswire (US) • 02/11/2026 01:30:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/05/2026 09:56:32 PM
